Jinxin Fertility Group Limited is a leading assisted reproductive services (“ARS”) provider in China and the United States. It owns and operates Chengdu Xinan Gynecological Hospital and Shenzhen Zhongshan Urological Hospital and jointly manage the IVF center of Jinjiang District Maternity and Child Health Hospital. Through its acquisition of HRC Management, the Group has enhanced its capabilities to provide high-value ARS to international patients, in particular, those from China. HRC Fertility is a leading full-service ARS provider in the United States with more than 30 years of experience and ranked first among all ARS providers in the United States.
Warburg Pincus is a leading global private equity firm focused on thesis-driven growth investing at scale. With more than $54 billion in assets under management, our active portfolio of more than 185 companies is highly diversified by stage, sector and geography. As an experienced partner to outstanding management teams, we help build durable companies with sustainable value. We have raised 19 private equity funds, which have invested more than $83 billion in over 895 companies in more than 40 countries.